WASHINGTON—Patients with gastric intestinal metaplasia had a 19-fold higher risk of developing gastric cancer compared with those who had normal gastric biopsy results, according to results from a new study.
In the long-term retrospective study of 1,743 patients, who were predominantly white, gastric cancer was diagnosed in 2.2% of patients for whom an earlier biopsy showed GIM, but in only one person—0.1%—without a finding of GIM (P<0.0001).
“What we are trying to